Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-07-09

FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)

View source ↗

Summary

FDA approved TEVA Pharmaceuticals USA Inc.'s supplemental application for glyburide. The drug is used to treat type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)